| Particulars |
|
|
|
|
Company Name
| Kabra Drugs Ltd
|
Year End
| 202503
|
| Full Year |
| Equity (₹ Cr.) |
23.71 |
B.V. (₹) |
11.00 |
| Sales(₹ Cr.) |
0.00 |
NP (₹ Cr.) |
-1.09 |
| NP Var% |
-47.00 |
Div% |
0.00 |
| CPS(₹) |
-0.50 |
EPS (₹) |
-0.50 |
| Traded Value(₹ Lakhs) |
17.31 |
52 Week High |
36.00 |
| 52 Week Low |
11.00 |
Price BSE |
31.00 |
| Price NSE |
0.00 |
Market Capital (₹ Cr.) |
72.43 |
| P/C Ratio |
-68.20 |
P/E Ratio |
-67.70 |
| Price Vs.BV |
2.82 |
|
| Latest Quarter |
| Year End |
202512 |
Sales (₹ Cr.) |
30.42 |
| NP(₹ Cr.) |
2.57 |
NP Var % |
578.00 |
| Trailing Twelve Months |
| Year End |
202512 |
Sales |
0.00 |
| OPM |
0.00 |
NP |
-1.42 |
| NP Var% |
332.28 |
EPS |
1.81 |
| PE |
16.88 |
|
|